SeekPeptides has compiled this comprehensive resource from peer-reviewed research, clinical documentation, and established peptide therapy protocols to give you evidence-based guidance on this intriguing compound
doi: 10.3390/ijms23126827 123
Lower-dose stop-short0.51.0mg/wk These doses have direct efficacy and safety data when used continuously
doi: 10.1111/ejn.15020 Summary Keywords dopamine D4 receptor, polymorphic variants, impulsivity, attention-deficit hyperactivity disorder, restless legs syndrome Citation Ferr S, Belcher AM, Bonaventura J, Quiroz C, Snchez-Soto M, Casad-Anguera V, Cai N-S, Moreno E, Boateng CA, Keck TM, Florn B, Earley CJ, Ciruela F, Casad V, Rubinstein M and Volkow ND (2022) Functional and pharmacological role of the dopamine D 4 receptor and its polymorphic variants